Clark, N., Hasselblad, V., Douketis, J., Spyropoulos, A., Kaatz, S., Becker, R., … Ortel, T. (2016). PREDICTORS OF MAJOR BLEEDING DURING WARFARIN INTERRUPTION FOR INVASIVE PROCEDURES: ANALYSIS OF THE BRIDGE TRIAL. AMERICAN JOURNAL OF HEMATOLOGY, 91(9), E391–E391.

Clark, Nathan, Vic Hasselblad, James Douketis, Alex Spyropoulos, Scott Kaatz, Richard Becker, Joseph Caprini, et al. “PREDICTORS OF MAJOR BLEEDING DURING WARFARIN INTERRUPTION FOR INVASIVE PROCEDURES: ANALYSIS OF THE BRIDGE TRIAL.” AMERICAN JOURNAL OF HEMATOLOGY 91, no. 9 (September 1, 2016): E391–E391.

Clark N, Hasselblad V, Douketis J, Spyropoulos A, Kaatz S, Becker R, et al. PREDICTORS OF MAJOR BLEEDING DURING WARFARIN INTERRUPTION FOR INVASIVE PROCEDURES: ANALYSIS OF THE BRIDGE TRIAL. AMERICAN JOURNAL OF HEMATOLOGY. 2016 Sep 1;91(9):E391–E391.

Clark, Nathan, et al. “PREDICTORS OF MAJOR BLEEDING DURING WARFARIN INTERRUPTION FOR INVASIVE PROCEDURES: ANALYSIS OF THE BRIDGE TRIAL.” AMERICAN JOURNAL OF HEMATOLOGY, vol. 91, no. 9, WILEY-BLACKWELL, Sept. 2016, pp. E391–E391.

Clark N, Hasselblad V, Douketis J, Spyropoulos A, Kaatz S, Becker R, Caprini J, Dunn A, Garcia D, Jacobson A, Jaffer A, Kong D, Schulman S, Turpie A, Ortel T. PREDICTORS OF MAJOR BLEEDING DURING WARFARIN INTERRUPTION FOR INVASIVE PROCEDURES: ANALYSIS OF THE BRIDGE TRIAL. AMERICAN JOURNAL OF HEMATOLOGY. WILEY-BLACKWELL; 2016 Sep 1;91(9):E391–E391.